{
  "docId": "019de072-c9ff-713b-84f0-a86291a57ca3",
  "docSlug": "36aaeca628c43c1081cab946857c1896",
  "documentTitle": "Navidea Biopharmaceuticals | Investor Presentation Deck | 18 slides",
  "authorId": "navidea-biopharmaceuticals",
  "authorName": "Navidea Biopharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 18,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a vertical list format to describe two specific clinical use cases for the product.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de072-c9ff-713b-84f0-a86291a57ca3/11",
  "deckHref": "/decks/019de072-c9ff-713b-84f0-a86291a57ca3",
  "deckJsonHref": "/decks/019de072-c9ff-713b-84f0-a86291a57ca3.json",
  "deckAnchorHref": "/decks/019de072-c9ff-713b-84f0-a86291a57ca3#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.32,
        "x": 0.11,
        "y": 0.65
      },
      "kind": "callout",
      "text": "Planned NDA submission 2024",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f890cbb4-27c8-4293-bfb3-68fcc7a04f92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.7,
        "y": 0.32
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "139c037d-c2e2-4282-bc26-03c355a94cec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.08,
        "y": 0.45
      },
      "kind": "list",
      "text": "Identify RA patients with low level of localization who are less likely to respond to anti-TNFa therapy. Imaging before treatment (low localization= low macrophage= no anti-TNF)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4bb98099-350a-4a8f-8fca-3dcff1d335c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.08,
        "y": 0.28
      },
      "kind": "list",
      "text": "Early prediction of RA treatment response to a new or first time anti-TNFa therapy. Imaging shortly after initiation of a new Tx",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "79f56a44-01bd-45fb-960a-fb9817014cbc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.08,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Quantitative Imaging with Tc 99m Tilmanocept for candidates of Anti-TNF Therapy",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0b2b64d-5682-445c-9662-5d78b8498700",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Our First Rheumatoid Arthritis Indications",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7b85d71-f0b0-4936-bf6a-97dc3e3b6ecc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 12,
      "from": 10,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "9c581025-b01b-4161-b805-cf27f7c79a9e",
      "evidence": "The section on Tc99m Tilmanocept prediction of treatment response presents it as a solution.",
      "position": 1,
      "objective": "Present Tc99m Tilmanocept as a quick win and big bet for rheumatoid arthritis treatment",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}